相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A pan-RAF inhibitor LY3009120 inhibits necroptosis by preventing phosphorylation of RIPK1 and alleviates dextran sulfate sodium-induced colitis
Chong Zhang et al.
CLINICAL SCIENCE (2019)
Cell Death and Inflammation - A Vital but Dangerous Liaison
Nieves Peltzer et al.
TRENDS IN IMMUNOLOGY (2019)
The anticonvulsive Phenhydan® suppresses extrinsic cell death
Caroline Moerke et al.
CELL DEATH AND DIFFERENTIATION (2019)
hsa-miR-500a-3P alleviates kidney injury by targeting MLKL-mediated necroptosis in renal epithelial cells
Ling Jiang et al.
FASEB JOURNAL (2019)
Wogonin protects against cisplatin-induced acute kidney injury by targeting RIPK1-mediated necroptosis
Xiao-Ming Meng et al.
LABORATORY INVESTIGATION (2018)
NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation
Xiao-Ming Meng et al.
LABORATORY INVESTIGATION (2018)
Klotho Reduces Necroptosis by Targeting Oxidative Stress Involved in Renal Ischemic-Reperfusion Injury
Yingying Qian et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury
Jinhua Tang et al.
CLINICAL SCIENCE (2018)
TLR2 and TLR4 play opposite role in autophagy associated with cisplatin-induced acute kidney injury
Magaiver Andrade-Silva et al.
CLINICAL SCIENCE (2018)
FGF21 is induced in cisplatin nephrotoxicity to protect against kidney tubular cell injury
Fanghua Li et al.
FASEB JOURNAL (2018)
Nox4 in renal diseases: An update
Qin Yang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2018)
Tozasertib Analogues as Inhibitors of Necroptotic Cell Death
Sam Hofmans et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Restoration of E-cadherin by PPBICA protects against cisplatin-induced acute kidney injury by attenuating inflammation and programmed cell death
Li Gao et al.
LABORATORY INVESTIGATION (2018)
ORIGIN AND CONSEQUENCES OF NECROINFLAMMATION
Maysa Sarhan et al.
PHYSIOLOGICAL REVIEWS (2018)
TWEAK and RIPK1 mediate a second wave of cell death during AKI
Diego Martin-Sanchez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Necrostatin-1 Attenuates Cisplatin-Induced Nephrotoxicity Through Suppression of Apoptosis and Oxidative Stress and Retains Klotho Expression
Yichun Ning et al.
FRONTIERS IN PHARMACOLOGY (2018)
RIPK3 promotes sepsis-induced acute kidney injury via mitochondrial dysfunction
Angara Sureshbabu et al.
JCI INSIGHT (2018)
AKI and Long-Term Risk for Cardiovascular Events and Mortality
Ayodele Odutayo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)
Management of patients at risk of acute kidney injury
Jill Vanmassenhove et al.
LANCET (2017)
CETSA quantitatively verifies in vivo target engagement of novel RIPK1 inhibitors in various biospecimens
Tsuyoshi Ishii et al.
SCIENTIFIC REPORTS (2017)
Quantitative analysis of necrostatin-1, a necroptosis inhibitor by LC-MS/MS and the study of its pharmacokinetics and bioavailability
Fang Geng et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure
Tammo Mueller et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
Inhibition of Necroptosis Attenuates Kidney Inflammation and Interstitial Fibrosis Induced By Unilateral Ureteral Obstruction
Xia Xiao et al.
AMERICAN JOURNAL OF NEPHROLOGY (2017)
Sustained Activation of Wnt/β-Catenin Signaling Drives AKI to CKD Progression
Liangxiang Xiao et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
αKlotho Mitigates Progression of AKI to CKD through Activation of Autophagy
Mingjun Shi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Regulation of necroptosis signaling and cell death by reactive oxygen species
Simone Fulda
BIOLOGICAL CHEMISTRY (2016)
RIPK3 deficiency or catalytically inactive RIPK1 provides greater benefit than MLKL deficiency in mouse models of inflammation and tissue injury
K. Newton et al.
CELL DEATH AND DIFFERENTIATION (2016)
Generation of small molecules to interfere with regulated necrosis
Alexei Degterev et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Classification of small molecule protein kinase inhibitors based upon the structures of their drug-enzyme complexes
Robert Roskoski
PHARMACOLOGICAL RESEARCH (2016)
How Kidney Cell Death Induces Renal Necroinflammation
Shrikant R. Mulay et al.
SEMINARS IN NEPHROLOGY (2016)
Protocatechuic Aldehyde Attenuates Cisplatin-Induced Acute Kidney Injury by Suppressing Nox-Mediated Oxidative Stress and Renal Inflammation
Li Gao et al.
FRONTIERS IN PHARMACOLOGY (2016)
A Role for Tubular Necroptosis in Cisplatin-Induced AKI
Yanfang Xu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
New tool for prediction of ESRD risk in living kidney donor candidates
Ellen F. Carney
Nature Reviews Nephrology (2015)
Regulation of tumour necrosis factor signalling: live or let die
Dirk Brenner et al.
NATURE REVIEWS IMMUNOLOGY (2015)
RIPK3-Mediated Necroptosis Regulates Cardiac Allograft Rejection
A. Pavlosky et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2014)
RIP3, a kinase promoting necroptotic cell death, mediates adverse remodelling after myocardial infarction
Mark Luedde et al.
CARDIOVASCULAR RESEARCH (2014)
Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis
X-N Wu et al.
CELL DEATH AND DIFFERENTIATION (2014)
RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis
S. Orozco et al.
CELL DEATH AND DIFFERENTIATION (2014)
Tubular p53 Regulates Multiple Genes to Mediate AKI
Dongshan Zhang et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Regulated Cell Death in AKI
Andreas Linkermann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis
Marius Dannappel et al.
NATURE (2014)
The role of iron and reactive oxygen species in cell death
Scott J. Dixon et al.
NATURE CHEMICAL BIOLOGY (2014)
The cellular thermal shift assay for evaluating drug target interactions in cells
Rozbeh Jafari et al.
NATURE PROTOCOLS (2014)
RIPK3-Mediated Necroptosis Promotes Donor Kidney Inflammatory Injury and Reduces Allograft Survival
A. Lau et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2013)
Receptor Interacting Protein Kinase 3 Is a Critical Early Mediator of Acetaminophen-induced Hepatocyte Necrosis in Mice
Anup Ramachandran et al.
HEPATOLOGY (2013)
Necroptosis: The Release of Damage-Associated Molecular Patterns and Its Physiological Relevance
Agnieszka Kaczmarek et al.
IMMUNITY (2013)
Temporal Changes in Incidence of Dialysis-Requiring AKI
Raymond K. Hsu et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
The RIP1-Kinase Inhibitor Necrostatin-1 Prevents Osmotic Nephrosis and Contrast-Induced AKI in Mice
Andreas Linkermann et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)
Structural Basis of RIP1 Inhibition by Necrostatins
Tian Xie et al.
STRUCTURE (2013)
A Role of RIP3-Mediated Macrophage Necrosis in Atherosclerosis Development
Juan Lin et al.
CELL REPORTS (2013)
Rip1 (Receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia/reperfusion injury
Andreas Linkermann et al.
KIDNEY INTERNATIONAL (2012)
Pathophysiology of ischemic acute kidney injury
Asif A. Sharfuddin et al.
NATURE REVIEWS NEPHROLOGY (2011)
Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
YoungSik Cho et al.
CELL (2009)
Necrostatin-1 reduces histopathology and improves functional outcome after controlled cortical impact in mice
Zerong You et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2008)